President & CEO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Michael Rice (insider trades) sold 37,500 shares of BLFS on 05/15/2020 at an average price of $14.84 a share. The total sale was $556,500.
BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation. BioLife Solutions Inc has a market cap of $313.930 million; its shares were traded at around $15.35 with a P/E ratio of 34.87 and P/S ratio of 13.53. GuruFocus has detected 4 severe warning signs with BioLife Solutions Inc. .
CEO Recent Trades:
- President & CEO Michael Rice sold 37,500 shares of BLFS stock on 05/15/2020 at the average price of $14.84. The price of the stock has increased by 3.44% since.
Directors and Officers Recent Trades:
- Exec VP & Chief Scientific Off Aby J. Mathew sold 10,000 shares of BLFS stock on 05/15/2020 at the average price of $14.29. The price of the stock has increased by 7.42% since.
- Exec VP & Chief Scientific Off Aby J. Mathew sold 20,000 shares of BLFS stock on 05/13/2020 at the average price of $14.41. The price of the stock has increased by 6.52% since.
For the complete insider trading history of BLFS, click here
.
